Clinical Trials Browser

Phase 3 × emactuzumab × 90 days × Clear all

NCT05417789 2026-02-02

TANGENT

Phase 3 Active not recruiting

Synovitis, Synovitis, Pigmented Villonodular

NCT03768063 2026-01-29

IMbrella B

Phase 3 Active not recruiting

Neoplasms